Pirfenidone Improves Familial Idiopathic Pulmonary Fibrosis without Affecting Serum Periostin Levels

Background: Antifibrotic agents have been approved for the treatment of idiopathic pulmonary fibrosis (IPF). However, the efficacy of these drugs in the treatment of familial IPF (FIPF) has not been previously reported. Case presentation: We report the case of a 77-year-old man with FIPF, successful...

Descripción completa

Detalles Bibliográficos
Autores principales: Koga, Yasuhiko, Hachisu, Yoshimasa, Tsurumaki, Hiroaki, Yatomi, Masakiyo, Kaira, Kyoichi, Ohta, Shoichiro, Ono, Junya, Izuhara, Kenji, Dobashi, Kunio, Hisada, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572615/
https://www.ncbi.nlm.nih.gov/pubmed/31108995
http://dx.doi.org/10.3390/medicina55050161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572615/
https://www.ncbi.nlm.nih.gov/pubmed/31108995
http://dx.doi.org/10.3390/medicina55050161

Ejemplares similares